IndraLab

Statements

Imatinib activates SCN11A. 1 / 1

| 1

reach

"For in vivo analysis, PN5 CD1 mice were treated with vehicle or imatinib (7.5 mg/kg i.p.) or cisplatin, (5 mg/kg i.p.) or both imatinib and cisplatin administered together (as in Gonfloni et al 3)."

22869179

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Imatinib activates SCN11A. 1 / 1

INDRA sources:

Databases

Reading